<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Seraj F</submitter><funding>Pakistan Academy of Sciences</funding><funding>Higher Education Commision, Pakistan</funding><pagination>2609-2625</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11731353</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(24)</volume><pubmed_abstract>&lt;b>Aim:&lt;/b> Quinoline scaffolds are serving as the core structure for numerous antifungal, analgesic, antipyretic, anti-inflammatory drugs as well as have also been investigated for their potential antidiabetic properties. Though further exploration is required in this area as the current antidiabetic agents, such as acarbose, miglitol and voglibose, are associated with several adverse side effects. In this context, arylated tetrahydrobenzo[&lt;i>H&lt;/i>]quinoline-3-carbonitrile derivatives were designed and evaluated as potential antidiabetic agents.&lt;b>Materials &amp; methods:&lt;/b> A one-pot multicomponent reaction of 6-methoxy-1-tetralone with ethyl cyanoacetate, ammonium acetate and varying aldehydes yielded a range of new arylated tetrahydrobenzo[&lt;i>h&lt;/i>]quinoline-3-carbonitrile molecules &lt;b>1-</pubmed_abstract><journal>Future medicinal chemistry</journal><pubmed_title>Synthesis of arylated tetrahydrobenzo[&amp;lt;i&amp;gt;H&amp;lt;/i&amp;gt;]quinoline-3-carbonitrile derivatives as potential hits for treatment of diabetes.</pubmed_title><pmcid>PMC11731353</pmcid><funding_grant_id>Project No. 111</funding_grant_id><funding_grant_id>HEC Indigenous 5000 Fellowship</funding_grant_id><pubmed_authors>Tariq SS</pubmed_authors><pubmed_authors>Baltas N</pubmed_authors><pubmed_authors>Naz F</pubmed_authors><pubmed_authors>Ozil M</pubmed_authors><pubmed_authors>Khan KM</pubmed_authors><pubmed_authors>Seraj F</pubmed_authors><pubmed_authors>Taha M</pubmed_authors><pubmed_authors>Salar U</pubmed_authors><pubmed_authors>Ul-Haq Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis of arylated tetrahydrobenzo[&amp;lt;i&amp;gt;H&amp;lt;/i&amp;gt;]quinoline-3-carbonitrile derivatives as potential hits for treatment of diabetes.</name><description>&lt;b>Aim:&lt;/b> Quinoline scaffolds are serving as the core structure for numerous antifungal, analgesic, antipyretic, anti-inflammatory drugs as well as have also been investigated for their potential antidiabetic properties. Though further exploration is required in this area as the current antidiabetic agents, such as acarbose, miglitol and voglibose, are associated with several adverse side effects. In this context, arylated tetrahydrobenzo[&lt;i>H&lt;/i>]quinoline-3-carbonitrile derivatives were designed and evaluated as potential antidiabetic agents.&lt;b>Materials &amp; methods:&lt;/b> A one-pot multicomponent reaction of 6-methoxy-1-tetralone with ethyl cyanoacetate, ammonium acetate and varying aldehydes yielded a range of new arylated tetrahydrobenzo[&lt;i>h&lt;/i>]quinoline-3-carbonitrile molecules &lt;b>1-</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-05-18T03:19:20.032Z</modification><creation>2026-05-18T03:13:01.993Z</creation></dates><accession>S-EPMC11731353</accession><cross_references><pubmed>39530526</pubmed><doi>10.1080/17568919.2024.2419359</doi></cross_references></HashMap>